Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01985971 · ClinicalTrials.gov registry record · NA
F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer
A NA study of Brain Metastases From Breast Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT01985971: Completed NA study of Brain Metastases From Breast Cancer, sponsored by Abramson Cancer Center at Penn Medicine.
NCT01985971 is a NA study of Brain Metastases From Breast Cancer that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01985971, a NA study of Brain Metastases From Breast Cancer, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
To estimate the presence of hypoxia in individual lesions after radiotherapy in patients with brain metastases from breast cancer as identified by F18 EF5 PET/CT imaging.
Conditions Studied
Interventions
- RADIATION PET/CT Imaging
Study Locations (1)
Pennsylvania
- Abramson Cancer Center of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-08-19 |
| Phase | NA |
What the finished NCT01985971 record still lists
NCT01985971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Brain Metastases From Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which PET/CT Imaging is the first listed.
NCT01985971 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01985971 about?
NCT01985971 is a clinical study titled "F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer". To estimate the presence of hypoxia in individual lesions after radiotherapy in patients with brain metastases from breast cancer as identified by F18 EF5 PET/CT imaging.
What is the current status of trial NCT01985971?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2011-03. Estimated completion is 2016-08-19.
What conditions does trial NCT01985971 study?
This clinical trial studies the following conditions: Brain Metastases From Breast Cancer.
What interventions are being tested in trial NCT01985971?
The interventions under investigation include: PET/CT Imaging (RADIATION).
Who is sponsoring clinical trial NCT01985971?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01985971 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01985971's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia